Magnetic Resonance for Triple-Negative Breast Cancer
Exploring ICAM1-targeting theranostic nanoparticles for magnetic resonance imaging and therapy of triple-negative breast cancer. Click to read more..
Source: dovepress.com
Stay updated with breaking news from Shanghai Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Exploring ICAM1-targeting theranostic nanoparticles for magnetic resonance imaging and therapy of triple-negative breast cancer. Click to read more..
Personalis, Inc. (NASDAQ:NASDAQ:PSNL) Q1 2022 Earnings Conference Call May 4, 2022, 5:00 PM ET Company Participants Caroline Corner - Investor Relations John West - President and CEO Aaron...